D-0521-2019 Class I Terminated
FDA drug recall D-0521-2019 was initiated by King Bio Inc. on Jul 20, 2018 and is designated Class I. Reason for recall: Microbial contamination The recall status is terminated (terminated Jan 19, 2022). Affected quantity: 105716 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Mar 20, 2019
- Initiation Date
- Jul 20, 2018
- Termination Date
- Jan 19, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 105716 bottles
Product Description
Dr. King's aquaflora Candida High Potency, 8 fl. oz. (236 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806 USA, UPC 35795580018, NDC 57955-8020-89
Reason for Recall
Microbial contamination
Distribution Pattern
U.S.A. Nationwide, Canada, and Australia.
Code Information
Lot Numbers: 120217R Exp. 12/19; 102017C Exp. 10/19; 101017G Exp. 10/19; 111417C Exp. 11/19; 062818E Exp. 06/20; 122817B Exp. 12/19; 030818B Exp. 03/20; 010716A Exp. 01/19; 011617H Exp. 01/20; 012517M Exp. 01/20; 020717A Exp. 02/20; 021816A Exp. 02/19; 031016C Exp. 03/19; 031016D Exp. 03/19; 033016K Exp. 03/19; 052516J Exp. 05/19; 052918G Exp. 05/20; 062116A Exp. 06/19; 062818A Exp. 06/20; 062818F Exp. 06/20; 090816B Exp. 06/20; 101216A Exp. 10/19; 112315A Exp. 11/18; 112916C Exp. 11/19; 120816N Exp. 12/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0521-2019
- openFDA file date
- Oct 6, 2026
- Loaded by RegDataLab
- Oct 12, 2026